Illuminoss Receives Additional Clearance for Bone Stabilization System

The system can be used to create an implant that conforms to the patient, providing strength and stability across the implant supporting the weakened bone.

The FDA has granted Illuminoss additional clearance for its photodynamic bone stabilization system.

The device can now be used by skeletally mature patients to treat traumatic, fragility, pathological and impending pathological fractures of the humerus, radius and ulna.

The system can be used to create an implant that conforms to the patient, providing strength and stability across the implant supporting the weakened bone. It is introduced by a minimally invasive procedure and allows for smaller incisions.